3: Initial statement of beneficial ownership of securities-Officer Christensen Bret

Feb 7 16:32 ET

8-K: Current report

Jan 30 16:46 ET

424B3: Prospectus

Nov 13, 2024 12:33 ET

10-Q: Q3 2024 Earnings Report

Nov 12, 2024 17:22 ET

8-K: Biote Reports Third Quarter 2024 Financial Results Continued Profitable Growth Vertical integration drives gross profit margin improvement Launch of proprietary clinical decision support software to strengthen competitive advantages

Nov 12, 2024 16:26 ET

SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BANDERA PARTNERS LLC(7.5%),GREGORY BYLINSKY(7.5%), etc.

Nov 12, 2024 16:21 ET

SC 13G: Statement of acquisition of beneficial ownership by individuals-BlackRock, Inc.(5.3%)

Nov 8, 2024 22:18 ET

SC 13G: Statement of acquisition of beneficial ownership by individuals-BlackRock, Inc.(5.3%)

Oct 22, 2024 18:08 ET

4: Statement of changes in beneficial ownership of securities-Officer Peterson Robert Charles

Sep 11, 2024 15:36 ET

424B3: Prospectus

Aug 9, 2024 14:57 ET

424B3: Prospectus

Aug 9, 2024 14:57 ET

10-Q: Q2 2024 Earnings Report

Aug 9, 2024 13:57 ET

8-K: Biote Reports Second Quarter 2024 Financial Results Procedure revenue growth accelerates sequentially BioteRx roll-out on track with further expansion planned Management reiterates 2024 financial guidance

Aug 8, 2024 16:48 ET

4: Statement of changes in beneficial ownership of securities-Officer Peterson Robert Charles

Jul 10, 2024 16:35 ET

8-K: Current report

Jul 5, 2024 16:08 ET

8-K: Current report

Jul 3, 2024 16:12 ET

8-K: Current report

Jun 21, 2024 14:16 ET

4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Director MORRIS DEBRA L

Jun 18, 2024 14:28 ET

8-K: Current report

May 24, 2024 07:31 ET

4: Statement of changes in beneficial ownership of securities-Director Jacoby Dana Lynn

May 23, 2024 16:13 ET